NCT01477632 - Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

MenopauseHealthy

Interventions

DRUG

0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)

A single oral dose of 2 tablets under fasting conditions

DRUG

0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA)

A single oral dose of 2 tablets under fasting conditions

DRUG

1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)

A single oral dose of 1 tablet under fasting conditions

Trial Locations (1)

Neu-Ulm